نتایج جستجو برای: vi mps

تعداد نتایج: 47894  

2018
Ryuichi Mashima Mari Ohira Torayuki Okuyama Akiya Tatsumi

Mucopolysaccharidosis (MPS) is a genetic disorder characterized by the accumulation of glycosaminoglycans in the body. Of the multiple MPS disease subtypes, several are caused by defects in sulfatases. Specifically, a defect in iduronate-2-sulfatase (ID2S) leads to MPS II, whereas N-acetylgalactosamine-6-sulfatase (GALN) and N-acetylgalactosamine-4-sulfatase (ARSB) defects relate to MPS IVA and...

Journal: :Revista Científica Hospital Santa Izabel 2023

Este estudo tem como objetivo mensurar a independência funcional de pacientes pediátricos com diagnóstico mucopolissacaridoses (MPS) na realização das atividades diárias. é um descritivo e transversal realizado enzimático confirmado para mucopolissacaridoses, atendidos no ambulatório Ortopedia hospital do interior da Bahia, Brasil. Os dados foram coletados entre outubro 2016 março 2017 partir a...

Journal: :Investigative ophthalmology & visual science 1983
G Aguirre L Stramm M Haskins

Feline mucopolysaccharidosis VI (MPS VI) is a recessively inherited deficiency of arylsulfatase B (ASB). In the eye, the disease is expressed by the intracytoplasmic accumulation of vacuolated inclusions. These are present in connective tissue cells in the cornea, conjunctiva, sclera, choroid, and the stroma of the iris and ciliary body. In the iris and ciliary body epithelia, only the nonpigme...

Journal: :Ortopedia, traumatologia, rehabilitacja 2013
Marcos Almeida Matos Rosa Barreto Angelina Xavier Acosta

BACKGROUND. The objective of this study is to evaluate the response of the musculoskeletal system to enzyme replacement therapy in a group of patients with Mucopolysaccharidosis (MPS). MATERIAL AND METHODS. A retrospective study was done based on records from 22 patients with different types of MPS (I, II and VI) who were treated with enzyme replacement therapy (ERT). Patient data were evaluate...

2012
Fiona L. Wilkinson Rebecca J. Holley Kia J. Langford-Smith Soumya Badrinath Aiyin Liao Alex Langford-Smith Jonathan D. Cooper Simon A. Jones J. Ed Wraith Rob F. Wynn Catherine L. R. Merry Brian W. Bigger

Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzymes, leading to GAG accumulation. Neurodegenerative MPS diseases exhibit cognitive decline, behavioural problems and shortened lifespan. We have characterised neuropathological changes in mouse models of MPSI, IIIA and IIIB to provide a better understanding of these events.Wild-type (WT), MPSI, I...

Journal: :archives of medical laboratory sciences 0
ali - esmaili department of hematology, school of allied medical sciences, iran university of medical sciences, tehran, iran fatemeh yari blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iran ali amini department of hematology, school of allied medical sciences, iran university of medical sciences, tehran, iran mohammad reza rezvani department of hematology, faculty of allied medicine, iran university of medical sciences,tehran,iran

this article reviews will focus on the concept and formation of micro particles (mps) in circulation and their role in transfusion medicine and immune system. mps are cell membrane derived vesicles which express markers of their parent cells and are found in circulation at low levels. exact functions of mps are unclear. in here, physiological almost all types of circulating mps including platel...

Journal: :genetics in the 3rd millennium 0
محمد حسن کریمی نژاد mohammad hassan kariminejad kariminejad - najmabadi pathology and genetics center, no: 1143 , 4th st. seyf ave. sanaat sq. shahrak-e-gharb ,tehran, iran tel : +9821-88363952-5 / fax : +9821-88083575 اتوپاوول ون دیگلن otto paul van diggelen clinical genetics department, erasmus university, rotterdam, netherlands

in 1902, well known archibald garrod applied mendels gene concept to human characters. he opened a new window in understanding the etiology of metabolic disorders. he proposed biochemical changes as the etiology of metabolic disorders in his series of papers inborn errors of metabolism (1906). after establishing prenatal diagnosis facilities for the detection of chromosomal abnormalities in our...

2015
David Satzer Christina DiBartolomeo Michael M. Ritchie Christine Storino Timo Liimatainen Hanne Hakkarainen Djaudat Idiyatullin Silvia Mangia Shalom Michaeli Ann M. Parr Walter C. Low

Type I mucopolysaccharidosis (MPS I) is an autosomal recessive lysosomal storage disorder with neurological features. Humans and laboratory animals with MPS I exhibit various white matter abnormalities involving the corpus callosum and other regions. In this study, we first validated a novel MRI technique, entitled Relaxation Along a Fictitious Field in the rotating frame of rank n (RAFFn), as ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید